1-3 of 3
Eiichi Ohtsuka, MD
Close
Sort by
Journal Articles

Favorable Outcomes of Newly Diagnosed Intravascular Large B-Cell Lymphoma Patients Treated with R-CHOP Combined with High-Dose Methotrexate Plus Intrathecal Chemotherapy: Results from a Multicenter Phase 2 Trial (PRIMEUR-IVL)

Kazuyuki Shimada, MD, Motoko Yamaguchi, MD PhD, Yoshiko Atsuta, MD PhD, Kosei Matsue, MD PhD, Keijiro Sato, MD, Shigeru Kusumoto, MD PhD, Hirokazu Nagai, MD PhD, Jun Takizawa, MD PhD, Noriko Fukuhara, MD PhD, Koji Nagafuji, MD PhD, Kana Miyazaki, MD PhD, Eiichi Ohtsuka, MD, Masataka Okamoto, MD PhD, Yasumasa Sugita, MD PhD, Toshiki Uchida, MD PhD, Satoshi Kayukawa, MD, Atsushi Wake, MD PhD, Daisuke Ennishi, MD PhD, Yukio Kondo, MD, Tohru Izumi, MD, Yoshihiro Kin, MD, Kunihiro Tsukasaki, MD PhD, Daigo Hashimoto, Masaaki Yuge, MD PhD, Atsumi Yanagisawa, Yachiyo Kuwatsuka, MD PhD, Satoko Shimada, MD, Yasufumi Masaki, MD PhD, Nozomi Niitsu, MD PhD, Hitoshi Kiyoi, MD PhD, Ritsuro Suzuki, MD PhD, Takashi Tokunaga, MD PhD, Shigeo Nakamura, MD, Tomohiro Kinoshita, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 350.
https://doi.org/10.1182/blood-2019-126798
Published: 2019
Journal Articles

Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy

Nobuhiko Yamauchi, Dai Maruyama, MD PhD, Ilseung Choi, MD PhD, Yoshiko Atsuta, MD PhD, Hirotaka Takasaki, MD PhD, Kazuho Miyashita, MD PhD, Yukiyoshi Moriuchi, MD, Hideki Tsujimura, MD PhD, Nobuko Kubota, MD PhD, Go Yamamoto, MD PhD, Tadahiko Igarashi, MD PhD, Koji Izutsu, MDPhD, Shinichiro Yoshida, MD PhD, Kensuke Kojima, MD PhD, Toshiki Uchida, MD PhD, Yoshiko Inoue, MD, Norifumi Tsukamoto, MD PhD, Eiichi Ohtsuka, MD PhD, Sachiko Suzuki, MD PhD, Yoko Inaguma, MD PhD, Satoshi Ichikawa, MD, Hiroshi Gomyo, MD, Yoko Ushijima, MD PhD, Kisato Nosaka, MD PhD, Mio Kurata, Yasuhito Tanaka, MD PhD, Ryuzo Ueda, MD PhD, Masashi Mizokami, MD PhD, Shigeru Kusumoto, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4209.
https://doi.org/10.1182/blood-2018-99-114850
Published: 2018
Journal Articles

Minimal Residual Disease Negative Status At the End of Induction Therapy Is a Potent Prognostic Marker in Adult Non-Ph Acute Lymphoblastic Leukemia: Results of the ALL MRD2002 Study

Koji Nagafuji, MD, PhD, Toshihiro Miyamoto, MD, PhD, Tetsuya Eto, MD, PhD, Tomohiko Kamimura, MD, Shuichi Taniguchi, MD, PhD, Takashi Okamura, MD, PhD, Eiichi Ohtsuka, MD, PhD, Takashi Yoshida, MD, Masakazu Higuchi, MD, PhD, Goichi Yoshimoto, MD, PhD, Tomoaki Fujisaki, MD, PhD, Yasunobu Abe, MD, PhD, Yasushi Takamatsu, MD, PhD, Shouhei Yokota, MD, PhD, Koichi Akashi, MD, PhD., Mine Harada, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2581.
https://doi.org/10.1182/blood.V118.21.2581.2581
Published: 2011